|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-2-9
|
|
pubmed:abstractText |
Most nonsteroidal anti-inflammatory drugs (NSAIDs) are non-selective cyclooxygenase-1 (COX-1) and COX-2 inhibitors and are associated with upper gastrointestinal (GI) dyspeptic symptoms often resulting in GI co-medication usage or treatment discontinuation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0300-7995
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1899-908
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15701208-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:15701208-Arthritis, Rheumatoid,
pubmed-meshheading:15701208-Cyclooxygenase Inhibitors,
pubmed-meshheading:15701208-Double-Blind Method,
pubmed-meshheading:15701208-Dyspepsia,
pubmed-meshheading:15701208-Humans,
pubmed-meshheading:15701208-Low Back Pain,
pubmed-meshheading:15701208-Osteoarthritis,
pubmed-meshheading:15701208-Patient Compliance,
pubmed-meshheading:15701208-Protective Agents,
pubmed-meshheading:15701208-Pyridines,
pubmed-meshheading:15701208-Randomized Controlled Trials as Topic,
pubmed-meshheading:15701208-Retrospective Studies,
pubmed-meshheading:15701208-Spondylitis, Ankylosing,
pubmed-meshheading:15701208-Sulfones
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
|
|
pubmed:affiliation |
Merck Research Laboratories, West Point, PA 19486, USA. douglas_watson@merck.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
